Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 134, Issue 3
July 18 2019
Issue Cover

Table of Contents

BLOOD COMMENTARIES

Lymphoid Neoplasia
Finding ARIEL under the sea of T-ALL circuits
Mark Y. Chiang
View Articletitled, Finding ARIEL under the sea of T-ALL circuits
Lymphoid Neoplasia
Is it time to revisit R-CHOP for primary CNS lymphoma?
Lakshmi Nayak,Tracy T. Batchelor
View Articletitled, Is it time to revisit R-CHOP for primary CNS lymphoma?
MYELOID NEOPLASIA
Triple-mutant AML: too clever by HLF?
George S. Vassiliou
View Articletitled, Triple-mutant AML: too clever by HLF?
TRANSPLANTATION
Joint effort to target the orphan of the orphan
Daniel Wolff
View Articletitled, Joint effort to target the orphan of the orphan

HEMATOPOIESIS AND STEM CELLS

Vitamin K antagonism impairs the bone marrow microenvironment and hematopoiesis
Divij Verma,Rahul Kumar,Raquel S. Pereira,Christina Karantanou,Costanza Zanetti,Valentina R. Minciacchi,Keertik Fulzele,Kathrin Kunz,Soraya Hoelper,Sara Zia-Chahabi,Marie-Joëlle Jabagi,Joseph Emmerich,Rosemary Dray-Spira,Franziska Kuhlee,Karl Hackmann,Evelin Schroeck,Philip Wenzel,Stefan Müller,Natalie Filmann,Michaela Fontenay,Paola Divieti Pajevic,Daniela S. Krause
View Articletitled, Vitamin K antagonism impairs the bone marrow microenvironment and hematopoiesis
Supplemental data

LYMPHOID NEOPLASIA

The enhancer RNA ARIEL activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia
Shi Hao Tan,Wei Zhong Leong,Phuong Cao Thi Ngoc,Tze King Tan,Fatima Carla Bertulfo,Mei Chee Lim,Omer An,Zhenhua Li,Allen Eng Juh Yeoh,Melissa J. Fullwood,Daniel G. Tenen,Takaomi Sanda

There is a Blood Commentary on this article in this issue.

View Articletitled, The enhancer RNA <em>ARIEL</em> activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia
Supplemental data
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma
Clinical Trials & Observations
Andrés J. M. Ferreri,Teresa Calimeri,Gian Marco Conte,Dario Cattaneo,Federico Fallanca,Maurilio Ponzoni,Eloise Scarano,Flavio Curnis,Alessandro Nonis,Paolo Lopedote,Giovanni Citterio,Letterio S. Politi,Marco Foppoli,Stefania Girlanda,Marianna Sassone,Salvatore Perrone,Caterina Cecchetti,Fabio Ciceri,Claudio Bordignon,Angelo Corti,Nicoletta Anzalone

There is a Blood Commentary on this article in this issue.

View Articletitled, R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma
Supplemental data

MYELOID NEOPLASIA

Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML
Swati Garg,Armando Reyes-Palomares,Lixiazi He,Anne Bergeron,Vincent-Philippe Lavallée,Sébastien Lemieux,Patrick Gendron,Christian Rohde,Jianglong Xia,Prarabdha Jagdhane,Carsten Müller-Tidow,Daniel B. Lipka,Suzan Imren,R. Keith Humphries,Claudia Waskow,Binje Vick,Irmela Jeremias,Guillaume Richard-Carpentier,Josée Hébert,Guy Sauvageau,Judith B. Zaugg,Frédéric Barabé,Caroline Pabst

There is a Blood Commentary on this article in this issue.

View Articletitled, Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome
Shengjiang Tan,Laëtitia Kermasson,Angela Hoslin,Pekka Jaako,Alexandre Faille,Abraham Acevedo-Arozena,Etienne Lengline,Dana Ranta,Maryline Poirée,Odile Fenneteau,Hubert Ducou le Pointe,Stefano Fumagalli,Blandine Beaupain,Patrick Nitschké,Christine Bôle-Feysot,Jean-Pierre de Villartay,Christine Bellanné-Chantelot,Jean Donadieu,Caroline Kannengiesser,Alan J. Warren,Patrick Revy
View Articletitled, EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome
Supplemental data

THROMBOSIS AND HEMOSTASIS

Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation
Lakmali Munasinghage Silva,Andrew Gary Lum,Collin Tran,Molly W. Shaw,Zhen Gao,Matthew J. Flick,Niki M. Moutsopoulos,Thomas H. Bugge,Eric S. Mullins
View Articletitled, Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation
Supplemental data

TRANSPLANTATION

Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria
CME
Geoffrey D. E. Cuvelier,Eneida R. Nemecek,Justin T. Wahlstrom,Carrie L. Kitko,Victor A. Lewis,Tal Schechter,David A. Jacobsohn,Andrew C. Harris,Michael A. Pulsipher,Henrique Bittencourt,Sung Won Choi,Emi H. Caywood,Kimberly A. Kasow,Monica Bhatia,Benjamin R. Oshrine,Allyson Flower,Sonali Chaudhury,Donald Coulter,Joseph H. Chewning,Michael Joyce,Süreyya Savaşan,Anna B. Pawlowska,Gail C. Megason,David Mitchell,Alexandra C. Cheerva,Anita Lawitschka,Lori J. West,Bo Pan,Yazid N. Al Hamarneh,Anat Halevy,Kirk R. Schultz

There is a Blood Commentary on this article in this issue.

View Articletitled, Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria
Supplemental data

LETTERS TO BLOOD

Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
Clinical Trials & Observations
H. Marijke van den Berg,Kathelijn Fischer,Manuel Carcao,Hervé Chambost,Gili Kenet,Karin Kurnik,Chris Königs,Christoph Male,Elena Santagostino,Rolf Ljung,on behalf of the PedNet Study Group,on behalf of the PedNet Study Group,on behalf of the PedNet Study Group,on behalf of the PedNet Study Group,on behalf of the PedNet Study Group,on behalf of the PedNet Study Group,on behalf of the PedNet Study Group,on behalf of the PedNet Study Group,on behalf of the PedNet Study Group,on behalf of the PedNet Study Group
View Articletitled, Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
Supplemental data
Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients
Clinical Trials & Observations
Masayoshi Tasaki,Paolo Milani,Andrea Foli,Laura Verga,Laura Obici,Marco Basset,Margherita Bozzola,Giovanni Ferraro,Mario Nuvolone,Patrizia Morbini,Gianluca Capello,Mitsuharu Ueda,Konen Obayashi,Marco Paulli,Yukio Ando,Giampaolo Merlini,Giovanni Palladini,Francesca Lavatelli
View Articletitled, Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients
Cuplike nuclear morphology is highly associated with IKZF1 deletion in pediatric precursor B-cell ALL
Weijie Li,Linda D. Cooley,Keith J. August,Aida I. Richardson,Lei Shao,Atif A. Ahmed,Midhat S. Farooqi,David L. Zwick
View Articletitled, Cuplike nuclear morphology is highly associated with <em>IKZF1</em> deletion in pediatric precursor B-cell ALL

BLOOD WORK

“Double-hit” follicular lymphoma
Shuo Xu,Qin Huang
View Articletitled, “Double-hit” follicular lymphoma

ERRATUM

Brady JL, Binkley MS, Hajj C, et al. Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG. Blood. 2019;133(3):237-245.
View Articletitled, Brady JL, Binkley MS, Hajj C, et al. Definitive radiotherapy for localized follicular lymphoma staged by <sup>18</sup>F-FDG PET-CT: a collaborative study by ILROG. <em>Blood</em>. 2019;133(3):237-245.

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS

Pediatric chronic graft-versus-host disease
CME
View Articletitled, Pediatric chronic graft-versus-host disease
All Issues

Advertisement intended for health care professionals

Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma
Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19
The Contribution of the Monocyte‐Macrophage Lineage to Immunotherapy Outcomes

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals